Tratamento Cirúrgico de Metástases Intracranianas
DOI:
https://doi.org/10.34024/rnc.2005.v13.8839Palavras-chave:
Tumores SNC, Metástases cerebrais, Neoplasias secundáriasResumo
Introdução: As metástases cerebrais formam o grupo de neoplasias mais freqüente do sistema nervoso central, e cerca de 40% dos pacientes com câncer desenvolvem metástases cerebrais. Pacientes com metástases únicas ou cujo quadro neurológico pode ser atribuído à lesão se beneficiam do tratamento cirúrgico. A evolução e o tratamento desta doença ainda permanecem controversos. Objetivos: Descrever as características clínicas e epidemiológicas dos pacientes com metástases cerebrais ressecadas no período de 2002 a 2003 no Hospital São Paulo. Métodos: Trabalho retrospectivo, descritivo, analítico, com coleta de dados baseada em revisão de prontuários de pacientes submetidos a ressecção cirúrgica de neoplasia secundária cerebral. Buscou-se a caracterização da população de estudo. Resultados: 30 pacientes foram avaliados (16 do sexo feminino). A média das idades dos pacientes foi de 52,9 ± 11,7 anos. As metástases de pulmão e mama compreenderam a maioria dos tumores operados. Houve desde então 12 óbitos registrados até a coleta de dados, com média de sobrevida pós-operatória de 72,92 dias, sendo o pior prognóstico relacionado às metástases de melanoma. Conclusão: As metástases cerebrais constituem ainda um grupo de doenças com prognóstico reservado, acometendo adultos economicamente ativos. Os pacientes com metástases de tumores de mama apresentaram tendência a maior sobrevida. A comparação de dados de diferentes centros é essencial para estabelecer a melhor conduta no tratamento destes casos.
Downloads
Métricas
Referências
Black PM, Johnson MD. Surgical resection for patients with solid brain metastases: current status. J Neurooncol 2004; 69(1-3): 119-24.
Nguyen T, Deangelis LM. Treatment of brain metastases. J Support Oncol 2004; 2(5):405-10 (discussion 411-6).
Bradley KA, Mehta MP. Management of brain metastases. Semin Oncol 2004; 31(5):693-701.
Kondziolka D, Patel A, Lunsford LD, Flickinger JC. Decision making for patients with multiple brain metastases: radiosurgery, radiotherapy, or resection? Neurosur Focus 2000; 9:1-6.
Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence Proportions of Brain Metastases In-Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J clin oncol 2004; 22(14): 2865-2872.
Takeshima H, Kuratsu J, Nishi T, Ushio Y. Prognostic Factors in Patients Who Survived More Than 10 Years after Undergoing Surgery forMetastatic Brain Tumors: Report of 5 cases and review of the literature. Surg Neurol 2002; 58:118-23.
Chang EL, Hassenbusch SJ 3rd, Shiu AS, et al. The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases. Neurosur 2003; 53(2): 272-80.
Ulm AJ, Friedman WA, Bova FJ, Bradshaw P, Amdur RJ, Mendenhall WM. Linear Accelerator Radiosurgery in the Treatment of Brain Metastases. Neurosur 2004; 55(5):1076-1085.
Okunieff P, Schell MC, Ruo R, Hale ER, O’Dell WG, Pilcher W. Long-term management of patients with multiple brain metastases after shaped beam radiosurgery. Case report and review of the literature. J Neurosurg 2004; 101 Suppl 3:406-12.
Warnick RE, Darakchiev BJ, Breneman JC. Stereotactic radiosurgery for patients with solid brain metastases: current status. J Neurooncol 2004; 69(1-3):125-37.
Schöggl A, Kitz K, Reddy M, Wolfsberger St, Schneider B, Dieckmann K, Ungersböck K. Defining the Role of Stereotactic Radiosurgery Versus Microsurgery in the Treatment of Single Brain Metastases. Acta Neurochir (Wien) 2000; 142:621-626.
Sheehan J, Niranjan A, Flickinger JC, Kondziolka D, Lunsford LD. The Expanding Role of Neurosurgeons in the Management of Brain Metastases. Surg Neurol 2004; 62:32–41.
Kimura T, Sako K, Tohyama Y, et al. Diagnosis and treatment of progressive space-occupying radiation necrosis following stereotactic radiosurgery for brain metastasis: Value of proton magnetic resonance spectroscopy. Acta Neurochir 2003, 145:557–564.
Pierallini A, Caramia F, Piattella MC, et al. Metastasis Along the Stereotactic Biopsy Trajectory in Glioblastoma Multiforme. Acta Neurochir (Wien) 1999; 141:1011- 012.
Bajard A, Westeel V, Dubiez A, et al. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma. Lung Cancer 2004; 45:317-323.
Rock JP, Haines S, Recht L, et al. Practice parameters for the management of single brain Metastasis. Neurosur Focus 2000; 9:1-9.
Mystakidou K, Boviatsis EJ , Kouyialis AT, et al. Silent radiological imaging time in patients with brain metastasis. Clin Neurol Neurosur 2004; 106: 300–304.
Shehata MK, Reid BYB, Patchell RA, et al. Stereotatic radiosurgery of 468 brain metastasis < 2 cm: Implications for SRS dose and whole brain radiation therapy. Int J Rad Oncol Biol Phys 2004; 59(1): 87–93.
Selek U, Chang EL, Hassenbusch III SJ, et al. Stereotatic radiosurgical treatment in 103 patientes for 153 cerebral melanoma metastases. Int. J. Rad Oncol Biol Phys 2004; 59(4): 1097–1106.
Datta R, Jawahar A, Ampil FL, Shi R, Nanda A, D’Agostino H. Survival in Relation to Radiotherapeutic Modality for Brain Metastasis. Whole Brain Irradiation vs. Gamma Knife Radiosurgery. Am J Clin Oncol 2004; 27(4): 420–424.
Kim DG, Kim CY, Paek SH, et al. Whole-Body [18F] FDG PET in the Management of Metastatic Brain Tumours. Acta Neurochir (Wien) 1998; 140:665-674.
Poon AN, Ho SS, Yeo W, Mok TS. Brain metastasis responding to gefitinib alone. Oncol 2004; 67(2): 174-8.
Chiocca EA, Broaddus WC, Gillies GT, Visted T, Lamfers MLM. Neurosurgical delivery of chemotherapeutics, targeted toxins, genetic and viral therapies in neuro-oncology. J Neuro-Oncol 2004; 69:101-117.
Downloads
Publicado
Como Citar
Edição
Seção
Publicado: 2005-03-31
Português
English
Español
